Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Although gastrointestinal adverse events (AEs), such as nausea, are more common in the 3 mg treatment group, other AEs such as hypoglycemic episodes and pancreatitis did not show dose dependency
Treatment will depend on the cause
Laboratory use only.
The study did not find clear increases in risk for suicidal behaviors associated with the GLP-1-RA class of medications among older adults when compared with SGLT2i or DPP4i medications. However, Guo noted that the estimates were imprecise, and researchers could not rule out a modest increase in risk, so more research is necessary to further evaluate this potential risk
Participants were required to have obesity at baseline, defined as BMI 30, or a diagnosis of obesity using International Classification of Diseases, Ninth and Tenth Revision (ICD-9 [ and ICD-10 [ registered in the VID medical record in the 365 days before the index date, and to be taking metformin on the index date
